Scientist, assistant professor at Columbia University Medical Center studying aneuploidy in cancer, posts are my own and do not represent views of CUIMC
Joined April 2018
- Tweets88
- Following149
- Followers443
- Likes165
Excited for the pub on our translational analyses suggesting different types of genomic alterations associated with response in NSCLC #jitc @BHenickMD @CatherineShuMD
New #JITC article: Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings bit.ly/49TdeqN @BHenickMD @DrMarkAwad @BizarMd @JustinGainor @CatherineShuMD
Excited about our new paper out in JCO Precision Oncology! Chr8q gain and MYC enhancer amplification correlates with African ancestry in lung SCC #jcopo
ascopubs.org/doi/10.1200/PO.…
Yes! We are very excited to be recruiting a shared computational biologist.
This is a fantastic opportunity to be involved in multiple projects and gain significant experience in diverse areas of cancer research within a supportive environment @Columbia. Formal job posting to come soon; DM for next steps. Re-tweets appreciated! 🙏🏼 2/2
Alison M. Taylor retweeted
This is a fantastic opportunity to be involved in multiple projects and gain significant experience in diverse areas of cancer research within a supportive environment @Columbia. Formal job posting to come soon; DM for next steps. Re-tweets appreciated! 🙏🏼 2/2
What a wonderful conference! And great talk today by lab graduate student Nadja Zhakula-Kostadinova! #AACRsynth24
Jolanta E. Grembecka, Serena J. Silver, Karen M. Cichowski, Janice Y. Lee, and Nadja Zhakula discussed "Translating the Next Synthetic Lethalities" in a plenary session at the AACR Conference on Cancer Synthetic Vulnerabilities. #AACRsynth24
Alison M. Taylor retweeted
Jolanta E. Grembecka, Serena J. Silver, Karen M. Cichowski, Janice Y. Lee, and Nadja Zhakula discussed "Translating the Next Synthetic Lethalities" in a plenary session at the AACR Conference on Cancer Synthetic Vulnerabilities. #AACRsynth24
Alison M. Taylor retweeted
I support the message my colleagues are sharing in today's @AACR Early-career Hill Day. I urge Congress to continue prioritizing medical research and support the highest possible funding increase for @NIH. #AACRontheHill @SenSchumer @SenGillibrand @RepJerryNadler – at Manhattan, NY
Today is the AACR Early-Career National Day of Action, and we're calling on early-career scientists, trainees, students, and all who support them to contact members of Congress and ask them to prioritize @NIH funding. Take action: AACR.org/AACRECHD24 #AACRontheHill #FundNIH
Agreed!!! Congratulations @ARustgi, well-deserved
What a great meeting!
Great to see Dr. Alison Taylor (@alisontaylorlab) and many more researchers representing @ColumbiaMed at this week's AI Meets Cancer Research Symposium in Barcelona!
Learn more about the work being presented by HICCC researchers: bsc.es/news/bsc-news/artific…
Out @Nature today! Excited to finally share our work led by Juliann Shih in collab w/ @RameenBeroukhim. Our algorithm “BISCUT” looks at large chromosomal changes and aneuploidy in cancer to detect genes that can account for effects on cellular fitness.
nature.com/articles/s41586-0…
My first time attending BAMM, what a great meeting! Thanks for organizing and inviting us! @KabecheLab
It’s a wrap! Wonderful day of cell division biology at BAMM 2023 . Thank you to all participants for making it such a fun and successful meeting, as well as fantastic co-organizers Lily Kabeche @KabecheLab and Dan Needleman, and our lab members. #BAMM #Meiosis #Mitosis
Alison M. Taylor retweeted
We are hiring a postdoctoral fellow for a fully funded position on how signaling enzymes regulate breast cancer growth! We welcome those interested in pivoting from basic biology into cancer biology. nature.com/naturecareers/job…
Wholeheartedly agree!!
📢📢New PIs: Apply for the NIH Early Career Reviewer (ECR) program. I recently served on a study section and learned so much about grant writing and the review process.
Eligibility: 1 year in a faculty position; no R01/R01-equivalent grant
public.csr.nih.gov/ForReview…
Alison M. Taylor retweeted
Our first (of many to come😃) exciting collaborative effort(s) with the @BizarMd Lab, led by superstars Yiping Wang @joy_lfan @JCA_Melms bringing multimodal single-nucleus RNA/TCR, spatial and whole-genome seq to the #clinical arena!
#cancergenomics #computationalbiology
‼️ JUST PUBLISHED @NatureGenet
📰 Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens
🧑🏿🤝🧑🏿 @elhamazizi Ben Izar and team
👇🏼
go.nature.com/3VZKkwy
Alison M. Taylor retweeted
Shoutout to this @CD_AACR paper by @CarrotJian and colleagues during the #AACRProjectGENIE session at #AACRdisp22
ICYMI in @CD_AACR: Genetic Ancestry Contributes to Somatic Mutations in #LungCancer from Admixed Latin American Populations by @CarrotJian @ogarrieta @AndresFCardonaZ Alexander Gusev, Matthew Meyerson, and colleagues #AACRdisp22 aacrjournals.org/cancerdisco…
#Aneuploidy22 was a fabulous meeting, thanks to the organizers for putting it together!
#Aneuploidy22 was a great scientific meeting and a fantastic opportunity to honour Angelika. Thanks to all the speakers, poster presenters and attendees for sharing their science and making it a successful and vibrant conference.
Alison M. Taylor retweeted
To all the Social DNAing fans, new registration is needed due to zoom license updates.
columbiacuimc.zoom.us/webina…
Alison M. Taylor retweeted
Structure-Based Classification System for EGFR Mutations May Help Clinicians Personalize Treatments for More Patients ilcn.org/structure-based-cla…
